BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Diaz-Gonzalez JA, Arbea L, Aristu J. Rectal cancer treatment: Improving the picture. World J Gastroenterol 2007; 13(44): 5805-5812 [PMID: 17990346 DOI: 10.3748/wjg.v13.i44.5805]
URL: https://www.wjgnet.com/1007-9327/full/v13/i44/5805.htm
Number Citing Articles
1
Béla Teleky. A rectum sebészeterMagyar Sebészet 2008; 61(6): 348 doi: 10.1556/maseb.61.2008.6.6
2
Leire Arbea, Rafael Martínez-Monge, Juan A. Díaz-González, Marta Moreno, Javier Rodríguez, Jose Luis Hernández, Jesús Javier Sola, Luis Isaac Ramos, Jose Carlos Subtil, Jorge Nuñez, Ana Chopitea, Mauricio Cambeiro, Miren Gaztañaga, Jesús García-Foncillas, Javier Aristu. Four-Week Neoadjuvant Intensity-Modulated Radiation Therapy With Concurrent Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer Patients: A Validation Phase II TrialInternational Journal of Radiation Oncology*Biology*Physics 2012; 83(2): 587 doi: 10.1016/j.ijrobp.2011.06.2008
3
Esther Uña, Francisco López-Lara. Pilot Study of a Clinical Pathway Implementation in Rectal CancerClinical Medicine Insights: Oncology 2010; 4: CMO.S4651 doi: 10.4137/CMO.S4651
4
Carolina De la Pinta, Margarita Martín, Asunción Hervás, Luis Cristian Perna, Eva Fernández-Lizarbe, Fernando López, Víctor Jose Duque, Sonsoles Sancho. Predictive factors for tumour response after the neoadjuvant-treatment of rectal adenocarcinomaJournal of Coloproctology 2020; 40(02): 112 doi: 10.1016/j.jcol.2019.10.013
5
Ron Shapiro, Usama Ahmed Ali, Ian C. Lavery, Ravi P. Kiran. Endorectal ultrasound does not reliably identify patients with uT3 rectal cancer who can avoid neoadjuvant chemoradiotherapyInternational Journal of Colorectal Disease 2013; 28(7): 993 doi: 10.1007/s00384-013-1645-5